Showing 501-510 of 1908 results for "".
Insights on Care for Skin of Color, Part 1
https://practicaldermatology.com/topics/skin-of-color/insights-on-care-for-skin-of-color-part-1/18184/The full spectrum of skin phototypes means that there is no "typical presentation" of skin disease. Host Neal Bhatia, MD speaks with James Q. Del Rosso, DO and Hilary Baldwin, MD about patients' needs during isolation and beyond.Skin-boosting: The New Frontier in Injectable Beauty
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/skin-boosting-the-new-frontier-in-injectable-beauty/19776/Dermatologists are increasingly using soft tissue fillers to hydrate the skin, explains Jeanette M. Black, M.D. By injecting certain hyaluronic acid fillers intradermally, it’s possible to increase hydration and glow, she says.Using the REVIAN Red System for Your Hair Loss Patients
https://practicaldermatology.com/topics/hair-nails/using-the-revian-red-system-for-your-hair-loss-patients/19754/Hear a few practical insights from hair loss experts Suneel Chilukuri, MD, Joel Cohen, MD and Michael Gold, MD about how they incorporate the new REVIAN Red dual-band LED wireless cap and smart app in their practices! REVIAN Red is indicated to treat androgenetic alopecia and to promote hair growthPigmentation Disorders
https://practicaldermatology.com/topics/pigmentary-disorders/pigmentation-disorders/19730/Sunscreen may be the first, second, and third thing recommended for patients with pigmentation disorders, but what comes next? Joel Cohen, MD interviews Amit Pandya, MD to learn about treatment options and developments in the pipeline.Mohs Certification: Finding a Middle Ground
https://practicaldermatology.com/topics/practice-management/mohs-certification-finding-a-middle-ground/18681/Can specialists reach a consensus on Mohs certification? Joel Schlessinger, MD, FAAD certainly hopes so. He spoke with DermTube.com about the controversy over certification for the surgical technique to treat skin cancer and urged compromise.DermWireTV: The Year in Review - 2023!
https://practicaldermatology.com/topics/psoriasis/dermwiretv-the-year-in-review-2023/20229/Practical Dermatology® Co-Chief Medical Editor, Joel Schlessinger, MD, shares his thoughts on some of the best products and approvals of 2023 as well as the potential of new JAK inhibitors to treat alopecia areata, vitiligo, psoriasis, and atopic dermatitis. Our new contributor, Andrew Mastro, PA, tHair Today
https://practicaldermatology.com/conferences/scale-2023/hair-today/20204/Joel L. Cohen, MD, and Doris Day, MD, discuss the latest advances in treating hair loss including the use of lasers with topicals, supplements, or PRP injections. They also discuss some of the risks associated with the use of biotin as a hair growth supplement.Of Sharks and Sunscreen
https://practicaldermatology.com/series/scientifically-speaking/of-sharks-and-sunscreen/20130/Often called on to judge "Shark Tank"-style competitions, Humberto Antunes has an eye for what makes an idea work. He talks with host Joel L. Cohen, MD about ingredients for success and also offers insight on sunscreen access in the US.Scientifically Speaking: Diagnosing and Treating Hair Loss, Part 1
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-diagnosing-and-treating-hair-loss-part-1/19954/Hair loss is distressing for many patients. The first step in management is to identify the cause of hair loss, modify contributing factors, and develop an effective treatment plan. Host Joel L. Cohen, MD discusses the challenges of managing hair loss with Marc Avram, MD, Cheryl Burgess, MD, and ReeToxin Time: What’s New and Exciting with Neuromodulators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/toxin-time-whats-new-and-exciting-with-neuromodulators/19768/Joel Cohen, MD takes a deep dive into the most recent data on neuromodulators including post-hoc analyses on the potential durability of response. Dr. Cohen also shares updates on Revance’s DAXI, Botox Cosmetic and liquid toxins under development by Galderma and Allergan.